Citations for
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
Bellanger A, Donini CF, Vendrell JA, Lavaud J, Machuca-Gayet I, Ruel M, Vollaire J, Grisard E, Győrffy B, Bièche I, Peyruchaud O, Coll JL, Treilleux I, Maguer-Satta V, Josserand V, Cohen PA.
J Pathol 242(1):73-89. doi: 10.1002/path.4882. Epub 2017 Mar 27. 2017
2SLC40A1, ZNF217
Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X, Zhang C, Qi S, Guo S, Chen Y, Du E, Zhang H, Wang X, Liu R, Qiao B, Yang K, Zhang Z, Xu Y.
Oncotarget 7(51):84893-84906. doi: 10.18632/oncotarget.12753. 2016
ZNF217/ZFP217 Meets Chromatin and RNA.
Lee DF, Walsh MJ, Aguiló F.
Trends Biochem Sci 41(12):986-988. doi: 10.1016/j.tibs.2016.07.013. Epub 2016 Aug 9. 2016
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
Cohen PA, Donini CF, Nguyen NT, Lincet H, Vendrell JA.
Oncotarget 6(39):41566-81. doi: 10.18632/oncotarget.5893. Review. 2015
ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.
Li J, Song L, Qiu Y, Yin A, Zhong M.
Int J Clin Exp Pathol 7(6):3038-47. eCollection 2014. 2014
New insights into DNA recognition by zinc fingers revealed by structural analysis of the oncoprotein ZNF217.
Vandevenne M, Jacques DA, Artuz C, Nguyen CD, Kwan AH, Segal DJ, Matthews JM, Crossley M, Guss JM, Mackay JP.
J Biol Chem 288(15):10616-27. doi: 10.1074/jbc.M112.441451. Epub 2013 Feb 22. 2013
TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex.
Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, Torchia J.
Mol Cell 46(5):636-49. doi: 10.1016/j.molcel.2012.03.027. Epub 2012 May 3. 2012
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, Vinot S, Bièche I, Grisard E, Josserand V, Coll JL, Roux P, Corbo L, Treilleux I, Rimokh R, Cohen PA.
Cancer Res 72(14):3593-606. doi: 10.1158/0008-5472.CAN-11-3095. Epub 2012 May 16. 2012
The multi-zinc finger protein ZNF217 contacts DNA through a two-finger domain.
Nunez N, Clifton MM, Funnell AP, Artuz C, Hallal S, Quinlan KG, Font J, Vandevenne M, Setiyaputra S, Pearson RC, Mackay JP, Crossley M.
J Biol Chem 286(44):38190-201. doi: 10.1074/jbc.M111.301234. Epub 2011 Sep 11. 2011
ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells.
Krig SR, Miller JK, Frietze S, Beckett LA, Neve RM, Farnham PJ, Yaswen PI, Sweeney CA.
Oncogene 29(40):5500-10. Epub 2010 Jul 26.PMID: 20661224 2010
The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.
Banck MS, Li S, Nishio H, Wang C, Beutler AS, Walsh MJ.
Epigenetics 4(2):100-6. Epub 2009 Feb 23.PMID: 19242095 2009
Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
Sun G, Zhou J, Yin A, Ding Y, Zhong M.
Int J Oncol 32(5):1065-71.PMID: 18425333 2008
Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence.
Cowger JJ, Zhao Q, Isovic M, Torchia J.
Oncogene 26(23):3378-86. Epub 2006 Nov 27. 2007
Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression.
Li P, Maines-Bandiera S, Kuo WL, Guan Y, Sun Y, Hills M, Huang G, Collins CC, Leung PC, Gray JW, Auersperg N.
Int J Cancer 120(9):1863-73. 2007
15CTBP1, ZNF217
Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins.
Quinlan KG, Nardini M, Verger A, Francescato P, Yaswen P, Corda D, Bolognesi M, Crossley M.
Mol Cell Biol 26(21):8159-72. Epub 2006 Aug 28. 2006
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C.
Hum Mol Genet 14(21):3219-25. Epub 2005 Oct 3. 2005
Positional cloning of ZNF217 and NABC1 : genes amplified at 20q13.2 and overexpressed in breast carcinoma.
Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, Gray JW.
Proc Natl Acad Sci U S A 95 : 8703-8708. 1998